The demographic and clinicopathologic factors associated with 5-year survivors have not been well documented in oesophageal squamous cell carcinoma (OSCC). We evaluated factors predictive of actual 5-year survival in the present research.
INTRODUCTION
Squamous cell carcinoma (SCC) accounts for most of the oesophageal malignant tumours in China, in contrast to the predominance of adenocarcinoma in the Western world [1] . The outcome of patients with oesophageal squamous cell carcinoma (OSCC) continues to be poor, with a 5-year survival rate ranging from 26.2% to 49.4% [2] [3] [4] [5] [6] [7] . However, all these survival rates are the estimated survival rates. The reports of actual 5-year survivors of OSCC are rare. According to the literature in recent years, many of the demographic and clinicopathologic factors are associated with survival following a surgical resection of OSCC. However, the prevalence of these factors in the actual 5-year survivors has not been well documented. The standard factors associated with improved actuarial survival such as T and N stage might be different from those associated with actual 5-year survival [8] . We sought to review and describe our institution's experience with oesophagectomy for invasive OSCC in order to identify factors associated with actual, not actuarial, 5-year survival.
MATERIALS AND METHODS

Study cohort
This retrospective study was approved by the ethics committee of Sun Yat-sen University Cancer Centre. The records of all patients underwent oesophagectomy for invasive OSCC at the Sun Yat-sen University Cancer Centre were identified. We excluded patients with high-grade dysplasia or carcinoma in situ, patients with cervical oesophageal carcinoma or gastrooesophageal junction carcinoma and patients who underwent surgical exploration without oesophagectomy. We also excluded patients with follow-up period under 5 years and patients who were lost within the first 5-year follow-up period. Finally, we identified 1241 patients who underwent oesophagectomy between 1996 and 2006. Two groups were identified and compared including those patients who were alive >5 years after oesophagectomy and those patients who died within 5 years of oesophagectomy.
approaches included the left transthoracic procedure, the Ivor Lewis approach, and the cervico-thoraco-abdominal procedure. The left transthoracic procedure and Ivor Lewis procedure with anastomosis of the upper chest were performed for all tumours of the lower thoracic oesophagus and some tumours of the middle thoracic oesophagus. The cervico-thoraco-abdominal procedure was used for all tumours of the upper thoracic oesophagus and some tumours of the middle thoracic oesophagus. Extensive lymph node dissection in the posterior mediastinum and abdomen was systematically performed. Cervical lymphadenectomy was not systematically undertaken. For patients with cervical anastomosis, the lymph nodes exposed in the cervical incision were also dissected. All resected specimens were submitted for pathologic examination. The pathologists made the pathologic diagnosis for primary tumours and the lymph nodes which were separately labelled by the surgeons. The lymph nodes examined also included the lymph nodes embedded in the en bloc specimen that were not labelled by surgeons but were identified by the pathologists.
Follow-up
A follow-up examination was generally carried out every 3 months for the first year, every 4 months for the second year and twice a year thereafter. Regular follow-up included physical examination, blood chemistry analysis, tumour markers (carcinoembryonic antigen, SCC antigen), computed tomography scan, oesophagography, ultrasonography and endoscopy. However, examinations were performed sooner if the patient had specific symptoms. Median follow-up time on all patients that were alive was 8 years.
Data retrieved
Patient demographics and clinicopathologic characteristics included age, gender, tumour location, severity of dysphagia, weight loss, co-morbidity, smoking history, alcohol abusing history, family history of any cancer, neoadjuvant treatment, pathologic complete response, surgical approach, completeness of resection, pathological T stage, pathological N stage, histologic grade, the number of metastatic lymph nodes, the number of resected lymph nodes, adjuvant treatment and length of survival. Tumour, node and metastasis descriptors, and the staging classification used for this analysis were those defined in the 7th edition of the American Joint Committee on Cancer staging manual.
Statistical analysis
Statistical analysis was performed by SPSS version 17.0 (SPSS, Chicago, IL, USA) statistical software. Continuous variables were compared by independent samples t-test. The mean values were described as mean ± standard deviation. The Pearson's chi-squared test was used to determine the significance of differences between groups for dichotomous variables. Logistic regression was used to compare the 5-year survival group with the non-5-year survival group in order to identify factors associated with 5-year survival. Two-sided P < 0.050 was considered statistically significant. Survival time was measured from the date of surgery to the date of death or last follow-up.
RESULTS
We identified 1241 patients who underwent oesophagectomy for invasive OSCC. Of these, 449 (36.2%) were actual 5-year survivors. Table 1 demonstrates the patient characteristics in the 5-year actual survivors and the non-5-year survivors. Univariate analysis showed that there were significant differences between the 5-year survivor group and the non-5-year survivor group regarding age, gender, weight loss, pathologic complete response, completeness of resection, pathological T stage, pathological N stage, histologic grade, the number of metastatic lymph nodes, the number of resected lymph nodes and adjuvant treatment. For the entire series, 73 (5.9%) underwent neoadjuvant therapy, and pathologic complete response rate was 15.1%. Although there was no significant difference between the two groups comparing the proportion receiving neoadjuvant therapy, the pathologic complete response rate of 5-year survivor group was higher than that in non-5-year survivor group. Showed by logistic regression analysis, significant factors associated with actual 5-year survival were younger patients, female gender, absence of weight loss, R0 resection, lower pathological T stage, lower pathological N stage, higher histologic grade and more resected lymph nodes. The details about logistic regression analysis were described in Table 2 .
DISCUSSION
Oesophageal squamous cell carcinoma is associated with a short median survival and a low rate of cure. It is important to understand risk factors in subsets of patients associated with a longterm survival. The standard factors such as T and N stage which are predictive of actuarial survival become less important as patients live for >5 years. Kim et al. [8] conducted a similar study, but the cancer type was adenocarcinoma in 74.0% and squamous cell carcinoma in 25.0%. We know that squamous and adenocarcinomas of the oesophagus are two different diseases [9] . So we evaluated factors predictive of >5-year survival of OSCC.
We reviewed the literature in recent years, and found out three studies on predictors of survival following a surgical resection of OSCC with large sample size.Li et al. analysed 605 patients who underwent oesophagectomy for OSCC. The 5-year overall survival of 605 patients was 36.0%. The independent prognostic factors identified by multivariate analysis were number of metastatic lymph node, histologic grade, tumour location, depth of invasion and vascular invasion [5] . Chen et al. reported 1715 patients with OSCC underwent extended oesophagectomy with a three-field lymph node dissection. The actuarial 5-year overall survival rate was 49.4%. Univariate and multivariate analyses showed that 60 years or more of age, male gender, tumour more than 5 cm long, poorly differentiated histology, T4 tumour, presence of a vascular cancer thrombus in the surgical specimen, lymph node positivity, three or more positive lymph nodes, and disease stage II or higher were the negative prognostic factors for the overall survival [3] . Yuequan et al. described 1553 patients with OSCC after surgery. The actuarial 5-year overall survival rate was 26.2%. Multivariate analysis showed that the independent prognostic factors were tumour size, histologic grade, pathological stage and family history of oesophageal cancer [2] .
In OSCC, it had not been definitely determined whether the long-term survival benefit was primarily due to either patient characteristics or tumour biology. Age as a prognostic factor of OSCC was controversial [3, 10] . In our research, there were more younger patients in the 5-year survivor group, and age was identified as a significant factor associated with an actual 5-year survival based on logistic regression analysis.However, Turkyilmaz et al. compared the survival rate between patients aged 40 years or less and aged over 40 years old, and found that younger patients did not have an improved 5-year survival compared with their older counterparts. The proportion of patients with OSCC in this study was 76.1%, and it was 88% and 75% in the young and old groups, respectively [10] .
The majority of researches demonstrated that female gender was a positive prognostic factor for the overall survival [3, [11] [12] [13] , including the present study. However, Cincibuch et al. concluded female gender was independent indicator of poor prognosis. What must be specially noted was that patients in the study were treated with chemoradiation not surgery and Co-morbidity included: tuberculosis, chronic obstructive pulmonary disease (COPD), history of intake of strong acid or alkali, peptic ulcers, gastrectomy, hepatitis, hypertension, coronary heart disease, diabetes, cerebral infarction.
adenocarcinoma patients were also included [11] . So we thought that it was inappropriate to identify predictors of long-term survival following surgical resection based on this research. The impacts of weight loss [11, 13, 14] , completeness of resection [15] , pathological T stage [3, 5, 7, 16, 17] , pathological N stage [2, 3, 5, 16, [18] [19] [20] [21] [22] , histologic grade [2, 3, 5, 22, 23] and the number of resected lymph nodes [2, 24, 25] on prognosis had been well proved by other investigators. In our study, these factors were also identified as independent predictors for actual 5-year survival.
The impact of the number of metastatic lymph nodes on prognosis had been considered as received consensus [3, 5] . In the present research, the number of metastatic lymph nodes in the 5-year survival group was significantly more than that of the non-5-year survival group. But it failed to be identified as an independent predictor for the actual 5-year survival.
Considerable controversy remained regarding improved longterm survival associated with neoadjuvant treatment [13] and adjuvant treatment [3, 13] . Although there was no significant difference between the two groups comparing the proportion receiving neoadjuvant therapy, the pathologic complete response rate of the 5-year survivor group was higher than that in the non-5-year survivor group. Pathologic complete response was considered as a stronger predictor than neoadjuvant treatment itself [4, 14] . Our study obtained a counterintuitive result about adjuvant treatment. More patients received adjuvant treatment in non-5-year survivor group. This result was possibly due to more patients with advanced stage in the non-5-year survivor group. We thought that adjuvant treatment itself had no effect on the actual 5-year survival.
In conclusion, the independent positive predictors for actual 5-year survival are younger patients, female gender, absence of weight loss, R0 resection, lower pathological T stage, lower pathological N stage, higher histologic grade and more resected lymph nodes.
The limitation of the current study included its retrospective format and thus, a comparison of 5-year survivors to non-5-year survivors are subject to selection bias. In addition, the study spanned many years and therapy modality has evolved over time with the increasing neoadjuvant and adjuvant treatment. Due to lack of detailed data on pathologic characteristics, the authors could not investigate the impact of vascular, perineural and extracapsular invasion on prognosis. 
